Related Experiment Video
Updated: May 20, 2026

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation
Published on: May 23, 2025
Topical therapies for periorbital cutaneous malignancies: indications and treatment regimens
1Eyelid, Lacrimal and Orbital Clinic, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia. tjs001@bigpond.net.au
Purpose Of Review:
To present a brief review of periorbital cutaneous tumorogenesis, highlighting the steps which might be amenable to topical treatments and then discuss the use of topical agents in the management of periorbital skin malignancy.
Recent Findings:
A rapid expansion in the understanding of the pathogenesis of melanoma and nonmelanoma skin cancer has allowed the development of a number of topical agents targeting specific tumor-forming processes. Topical agents have been shown to be effective in the management of periorbital skin malignancy.
Summary:
5-Fluorouracil and imiquimod have established roles in the management of periorbital skin malignancy. Newer agents such as ingenol mebutate, tazarotene, and diclofenac gel probably have evolving roles that require further research but show promise.
Insights
Topical treatments show promise for periorbital skin cancers. Established agents like 5-fluorouracil and imiquimod are effective, while newer options require further research for managing skin tumors around the eyes.
Area of Science:
- Dermatology
- Oncology
Background:
- Periorbital skin cancers, including melanoma and nonmelanoma types, pose unique management challenges.
- Understanding the pathogenesis of these tumors is crucial for developing targeted therapies.
Purpose of the Study:
- To review periorbital cutaneous tumorogenesis.
- To identify stages amenable to topical treatments.
- To discuss the efficacy of topical agents in managing periorbital skin malignancies.
Main Methods:
- Literature review of studies on periorbital tumorogenesis.
- Analysis of research on topical agents for skin cancer treatment.
- Evaluation of clinical data on the use of 5-fluorouracil, imiquimod, ingenol mebutate, tazarotene, and diclofenac gel.
Main Results:
- Advances in understanding skin cancer pathogenesis have led to targeted topical agents.
- Topical therapies have demonstrated effectiveness in treating periorbital skin cancers.
- Established agents like 5-fluorouracil and imiquimod are key players.
Conclusions:
- 5-Fluorouracil and imiquimod are proven treatments for periorbital skin malignancies.
- Emerging agents like ingenol mebutate, tazarotene, and diclofenac gel show potential but need more research.
- Topical treatments offer a promising avenue for managing skin tumors in the periorbital region.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy
Local Anesthetics: Common Agents and Their Applications
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
